Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
ChEMBL ligand: CHEMBL285932 (AM-251) |
---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
---|---|---|---|---|---|---|---|---|
CB1 receptor/Cannabinoid CB1 receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL218] [GtoPdb: 56] [UniProtKB: P21554] | ||||||||
ChEMBL | Antagonist activity at CB1 receptor (unknown origin) | B | 8.12 | pKi | 7.5 | nM | Ki | Med Chem Res (2013) 22: 4133-4145 |
ChEMBL | Binding affinity to cannabinoid CB1 receptor | B | 8.13 | pKi | 7.49 | nM | Ki | J. Med. Chem. (2010) 53: 4332-4353 [PMID:20218623] |
ChEMBL | Antagonist activity at CB1 receptor (unknown origin) | B | 8.13 | pKi | 7.48 | nM | Ki | Med Chem Res (2013) 22: 4133-4145 |
ChEMBL | Binding affinity to human CB1 receptor | B | 8.52 | pKi | 3 | nM | Ki | Bioorg. Med. Chem. Lett. (2007) 17: 3978-3982 [PMID:17513109] |
ChEMBL | Displacement of [3H]CP-55940 from human recombinant CB1 receptor expressed in HEK cells | B | 8.64 | pKi | 2.3 | nM | Ki | Bioorg. Med. Chem. (2009) 17: 5549-5564 [PMID:19595596] |
ChEMBL | Displacement of [3H]CP-55940 from human recombinant CB1 receptor expressed in HEK cells | B | 8.64 | pKi | 2.3 | nM | Ki | Bioorg. Med. Chem. (2008) 16: 7510-7515 [PMID:18579386] |
ChEMBL | Displacement of [3H]CP-55,940 from recombinant human CB1 receptor transfected in HEK cells | B | 8.64 | pKi | 2.3 | nM | Ki | Eur. J. Med. Chem. (2010) 45: 5878-5886 [PMID:20943290] |
ChEMBL | Displacement of [3H]CP-55940 from human recombinant CB1 receptor expressed in HEK cells | B | 8.64 | pKi | 2.3 | nM | Ki | J. Med. Chem. (2008) 51: 1560-1576 [PMID:18293908] |
ChEMBL | Displacement of [3H]CP-55940 from human CB1R F170L mutant expressed in CHO cells | B | 6.47 | pIC50 | 340 | nM | IC50 | J. Med. Chem. (2008) 51: 2108-2114 [PMID:18333607] |
ChEMBL | Displacement of [3H]CP-55940 from human CB1R W279A mutant expressed in CHO cells | B | 6.72 | pIC50 | 190 | nM | IC50 | J. Med. Chem. (2008) 51: 2108-2114 [PMID:18333607] |
ChEMBL | Displacement of [3H]CP-55940 from human CB1R K192L mutant expressed in CHO cells | B | 7.22 | pIC50 | 60 | nM | IC50 | J. Med. Chem. (2008) 51: 2108-2114 [PMID:18333607] |
ChEMBL | Displacement of [3H]CP-55940 from human CB1R F200L mutant expressed in CHO cells | B | 7.52 | pIC50 | 30 | nM | IC50 | J. Med. Chem. (2008) 51: 2108-2114 [PMID:18333607] |
ChEMBL | Displacement of [3H]CP-55940 from human wild type CB1R expressed in CHO cells | B | 8.46 | pIC50 | 3.5 | nM | IC50 | J. Med. Chem. (2008) 51: 2108-2114 [PMID:18333607] |
ChEMBL | Displacement of [3H]SR-141716 from human CBR1 S383A mutant expressed in CHO cells | B | 9.23 | pIC50 | 0.59 | nM | IC50 | J. Med. Chem. (2008) 51: 2108-2114 [PMID:18333607] |
ChEMBL | Displacement of [3H]SR-141716 from human wild type CB1R expressed in CHO cells | B | 9.49 | pIC50 | 0.32 | nM | IC50 | J. Med. Chem. (2008) 51: 2108-2114 [PMID:18333607] |
ChEMBL | Inverse agonist activity at human CB1 receptor expressed in Sf9 cells coexpressing Gbeta1gamma2 and RSG4 assessed as degradation of [gamma-33P]GTP after 20 mins by steady-state GTPase assay | B | 7.15 | pEC50 | 70 | nM | EC50 | Bioorg. Med. Chem. Lett. (2014) 24: 4209-4214 [PMID:25096297] |
ChEMBL | Inverse agonist activity at human CB1 receptor expressed in Sf9 cells coexpressing Gbeta1gamma2 and RSG4 assessed as degradation of [gamma-33P]GTP after 20 mins by steady-state GTPase assay | B | 7.17 | pEC50 | 67.61 | nM | EC50 | Bioorg. Med. Chem. Lett. (2014) 24: 4209-4214 [PMID:25096297] |
ChEMBL | Inverse agonist activity at human CB1 receptor expressed in Sf9 cells coexpressing Galpha i2 assessed as Galpha GTPase activity using [gamma-33P]GTP by scintillation counting in presence of CP55940 | B | 7.24 | pEC50 | 57.54 | nM | EC50 | Bioorg. Med. Chem. (2014) 22: 3938-3946 [PMID:24984935] |
CB1 receptor/Cannabinoid CB1 receptor in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3571] [GtoPdb: 56] [UniProtKB: P20272] | ||||||||
GtoPdb | - | - | 8.1 | pKi | 7.94 | nM | Ki | J Med Chem (1999) 42: 769-76 [PMID:10052983] |
ChEMBL | Binding affinity against Cannabinoid receptor 1 in rat forebrain | B | 8.13 | pKi | 7.49 | nM | Ki | J. Med. Chem. (1999) 42: 769-776 [PMID:10052983] |
ChEMBL | Inhibition of [3H]CP-55940 binding to cannabinoid receptor 1 in rat brain membranes. | B | 8.22 | pKi | 6 | nM | Ki | J. Med. Chem. (2002) 45: 1447-1459 [PMID:11906286] |
ChEMBL | Binding affinity was determined by using a competition assay with [125 I]- AM251 against rat cannabinoid receptor 1 | B | 9.22 | pKi | 0.6 | nM | Ki | J. Med. Chem. (2003) 46: 642-645 [PMID:12570386] |
CB2 receptor/Cannabinoid CB2 receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL253] [GtoPdb: 57] [UniProtKB: P34972] | ||||||||
ChEMBL | Binding affinity to cannabinoid CB2 receptor | B | 5.64 | pKi | 2290 | nM | Ki | J. Med. Chem. (2010) 53: 4332-4353 [PMID:20218623] |
ChEMBL | Displacement of [3H]CP 55940 from human CB2 receptor in cell free system | B | 6.95 | pKi | 112.2 | nM | Ki | Eur. J. Med. Chem. (2011) 46: 547-555 [PMID:21183257] |
ChEMBL | Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in HEK cells | B | 6.95 | pKi | 112 | nM | Ki | J. Med. Chem. (2008) 51: 1560-1576 [PMID:18293908] |
ChEMBL | Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in HEK cells | B | 6.95 | pKi | 112 | nM | Ki | Bioorg. Med. Chem. (2009) 17: 5549-5564 [PMID:19595596] |
ChEMBL | Displacement of [3H]CP-55,940 from recombinant human CB2 receptor transfected in HEK cells | B | 6.95 | pKi | 112 | nM | Ki | Eur. J. Med. Chem. (2010) 45: 5878-5886 [PMID:20943290] |
ChEMBL | Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in HEK cells | B | 6.96 | pKi | 110 | nM | Ki | Bioorg. Med. Chem. (2008) 16: 7510-7515 [PMID:18579386] |
CB2 receptor/Cannabinoid CB2 receptor in Mouse (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5373] [GtoPdb: 57] [UniProtKB: P47936] | ||||||||
ChEMBL | Binding affinity against Cannabinoid receptor 2 in mouse spleen | B | 5.64 | pKi | 2290 | nM | Ki | J. Med. Chem. (1999) 42: 769-776 [PMID:10052983] |
GPR55/G-protein coupled receptor 55 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1075322] [GtoPdb: 109] [UniProtKB: Q9Y2T6] | ||||||||
ChEMBL | Agonist activity at human GPR55 expressed in HEK293 cells assessed as increase in oscillation Ca2+ transients by fura-2 dye based fluorescence analysis | F | 6.2 | pEC50 | 630 | nM | EC50 | MedChemComm (2014) 5: 632-649 |
GtoPdb | - | - | 7.41 | pEC50 | 39 | nM | EC50 |
Br J Pharmacol (2007) 152: 1092-101 [PMID:17876302]; Br J Pharmacol (2010) 160: 604-14 [PMID:20136841]; J Biol Chem (2009) 284: 29817-27 [PMID:19723626] |
GPR18 in Human [GtoPdb: 89] [UniProtKB: Q14330] | ||||||||
GtoPdb | - | - | 4.02 | pEC50 | 96400 | nM | EC50 | Br J Pharmacol (2012) 165: 2414-24 [PMID:21595653] |
ChEMBL data shown on this page come from version 31:
Gaulton A, Hersey A, Nowotka M, Bento AP, Chambers J, Mendez D, Mutowo P, Atkinson F, Bellis LJ, CibriƔn-Uhalte E, Davies M, Dedman N, Karlsson A, MagariƱos MP, Overington JP, Papadatos G, Smit I, Leach AR. (2017) 'The ChEMBL database in 2017.' Nucleic Acids Res., 45(D1). DOI: 10.1093/nar/gkw1074. [PMCID:5210557]